Denbury
NYSE:DENDenbury Inc. operates as an independent energy company in the Gulf Coast and Rocky Mountain regions. It holds interests in various oil and natural gas properties located in Mississippi, Texas, and Louisiana in the Gulf Coast region; and in Montana, North Dakota, and Wyoming in the Rocky Mountain region. The company was formerly known as Denbury Resources Inc. and changed its name to Denbury Inc. in September 2020. Denbury Inc. was founded in 1951 and is headquartered in Plano, Texas.
Niko Resources
TSE:NKONiko Resources Ltd. engages in the exploration, development, and production of oil and natural gas in India and Bangladesh. It primarily holds interests in the D6 Block consisting of Dhirubhai 1 and 3 Fields, MA Field, R cluster development project, satellite cluster development project, and MJ field development project located off the coastline of Andhra Pradesh, India; and the Block 9 in the central area of Bangladesh. The company was founded in 1987 and is headquartered in Calgary, Canada.
Protalix BioTherapeutics
NYSE:PLXProtalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also developing PRX-115, a plant cell-expressed recombinant PEGylated Uricase which is in Phase I trial for the treatment of gout; and PRX-119, a plant cell-expressed PEGylated recombinant human DNase I product candidate that is in preclinical phase for the treatment of NETs-related diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz; and Chiesi Farmaceutici S.p.A. The company was incorporated in 1993 and is headquartered in Carmiel, Israel. Protalix BioTherapeutics, Inc. is a subsidiary of Protalix Ltd.
Wavefront Technology Solutions
CVE:WEEWavefront Technology Solutions Inc. develops fluid injection technologies for oil and gas well stimulation, and improved/enhanced oil recovery in Canada. The company offers Powerwave process, an injection technology that improves the flow of fluids in geological materials, including sedimentary soils and fractured rock; and Primawave process, a method for aiding in-ground environmental remediation clean-up in contaminated sites. Wavefront Technology Solutions is headquartered in Edmonton, Canada.